ConductScience.org, home
Dose-Response and Pharmacokinetics of Gabapentin Enacarbil (GEn [XP13512 / GSK1838262]) in Restless Legs Syndrome
API referenceFor AI assistants

Trial · NCT01332305

Results by group40

Each measurement the trial posted, group by group, in the words and numbers it posted.

1 to 20 of 40

Download this page as JSON
OutcomeGroupCategoryValueSpreadUnits
Mean Css, Max and Css, MinGEn 600 mgCss, max; Week 4, n=0, 39, 33, 33, 363.86Standard Deviation 1.25nanograms per milliliter (ng/ml)
Mean Css, Max and Css, MinGEn 1200 mgCss, max; Week 4, n=0, 39, 33, 33, 367.14Standard Deviation 2.62nanograms per milliliter (ng/ml)
Mean Css, Max and Css, MinGEn 1800 mgCss, max; Week 4, n=0, 39, 33, 33, 3611.4Standard Deviation 3.54nanograms per milliliter (ng/ml)
Mean Css, Max and Css, MinGEn 2400 mgCss, max; Week 4, n=0, 39, 33, 33, 3614.0Standard Deviation 4.23nanograms per milliliter (ng/ml)
Mean Css, Max and Css, MinGEn 600 mgCss, max; Week 12, n=0, 32, 30, 30, 314.14Standard Deviation 1.19nanograms per milliliter (ng/ml)
Mean Css, Max and Css, MinGEn 1200 mgCss, max; Week 12, n=0, 32, 30, 30, 317.15Standard Deviation 2.76nanograms per milliliter (ng/ml)
Mean Css, Max and Css, MinGEn 1800 mgCss, max; Week 12, n=0, 32, 30, 30, 3112.0Standard Deviation 3.83nanograms per milliliter (ng/ml)
Mean Css, Max and Css, MinGEn 2400 mgCss, max; Week 12, n=0, 32, 30, 30, 3113.3Standard Deviation 3.83nanograms per milliliter (ng/ml)
Mean Css, Max and Css, MinGEn 600 mgCss, min; Week 4, n=0, 39, 33, 33, 360.690Standard Deviation 0.359nanograms per milliliter (ng/ml)
Mean Css, Max and Css, MinGEn 1200 mgCss, min; Week 4, n=0, 39, 33, 33, 361.37Standard Deviation 0.894nanograms per milliliter (ng/ml)
Mean Css, Max and Css, MinGEn 1800 mgCss, min; Week 4, n=0, 39, 33, 33, 361.63Standard Deviation 0.967nanograms per milliliter (ng/ml)
Mean Css, Max and Css, MinGEn 2400 mgCss, min; Week 4, n=0, 39, 33, 33, 362.34Standard Deviation 1.78nanograms per milliliter (ng/ml)
Mean Css, Max and Css, MinGEn 600 mgCss, min; Week 12, n=0, 32, 30, 30, 310.600Standard Deviation 0.332nanograms per milliliter (ng/ml)
Mean Css, Max and Css, MinGEn 1200 mgCss, min; Week 12, n=0, 32, 30, 30, 311.32Standard Deviation 1.15nanograms per milliliter (ng/ml)
Mean Css, Max and Css, MinGEn 1800 mgCss, min; Week 12, n=0, 32, 30, 30, 311.60Standard Deviation 0.994nanograms per milliliter (ng/ml)
Mean Css, Max and Css, MinGEn 2400 mgCss, min; Week 12, n=0, 32, 30, 30, 312.41Standard Deviation 1.29nanograms per milliliter (ng/ml)
Mean Tmax and T1/2GEn 600 mgTmax; Week 4, n=0, 39, 33, 33, 368.76Standard Deviation 3.81hours
Mean Tmax and T1/2GEn 1200 mgTmax; Week 4, n=0, 39, 33, 33, 368.57Standard Deviation 3.16hours
Mean Tmax and T1/2GEn 1800 mgTmax; Week 4, n=0, 39, 33, 33, 367.61Standard Deviation 2.67hours
Mean Tmax and T1/2GEn 2400 mgTmax; Week 4, n=0, 39, 33, 33, 368.01Standard Deviation 3.62hours

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Next page

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT01332305/results

API referenceFor AI assistants